AI tool offers early warning system for drug shortages
  • Jul 08, 2026

AI tool offers early warning system for drug shortages

Ottawa lost more than $10M in health equipment after 2024 flood: Report
  • Jul 07, 2026

Ottawa lost more than $10M in health equipment after 2024 flood: Report

What are peptides? And why am I hearing so much about them?
  • Jul 07, 2026

What are peptides? And why am I hearing so much about them?

Health Canada warns doctors not to start this prescription medication
  • Jul 07, 2026

Health Canada warns doctors not to start this prescription medication

Health Canada permits temporary import of Chinese-authorized chemo injection drug amid critical shortage
  • Jul 03, 2026

Health Canada permits temporary import of Chinese-authorized chemo injection drug amid critical shortage

mRNA vaccines proved safe and effective during COVID, review says. Cancer could be next
  • Jul 02, 2026

mRNA vaccines proved safe and effective during COVID, review says. Cancer could be next

Auditor-General stands down in favour of government review of PrescribeIT
  •  —
  • Jul 02, 2026

Auditor-General stands down in favour of government review of PrescribeIT

Health Canada approves first generic semaglutide for weight loss
  • Jun 29, 2026

Health Canada approves first generic semaglutide for weight loss

‘We’re running blind’: Ontario pharmacist sounds alarm on drug shortages
  • Jun 25, 2026

‘We’re running blind’: Ontario pharmacist sounds alarm on drug shortages

Drug that delays onset of type 1 diabetes approved in England and Wales
  • Jun 23, 2026

Drug that delays onset of type 1 diabetes approved in England and Wales

New treatment option arrives for Canadians with sleep apnea and obesity
  • Jun 22, 2026

New treatment option arrives for Canadians with sleep apnea and obesity

Canada eliminates phase III trial requirement for biosimilar approvals
  • Jun 22, 2026

Canada eliminates phase III trial requirement for biosimilar approvals

Key FDA committee unanimously recommends its first vaccine since 2023
  • Jun 19, 2026

Key FDA committee unanimously recommends its first vaccine since 2023

Access to free naloxone in B.C. preventing 4 out of 5 potentially fatal overdoses, report finds
  • Jun 19, 2026

Access to free naloxone in B.C. preventing 4 out of 5 potentially fatal overdoses, report finds

NHS patients face worst drug shortages on record, say pharmacists and GPs
  • Jun 18, 2026

NHS patients face worst drug shortages on record, say pharmacists and GPs

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
  • Jun 18, 2026

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

Alberta strikes new deal with pharmacists, dispensing fees to see small bump
  • Jun 16, 2026

Alberta strikes new deal with pharmacists, dispensing fees to see small bump

Antidepressants and antipsychotics could serve as alternatives to opioids, study finds
  • Jun 15, 2026

Antidepressants and antipsychotics could serve as alternatives to opioids, study finds

Cheaper generic Ozempic is here. Here’s what we’ve learned since these drugs exploded onto the scene
  •  —
  • Jun 15, 2026

Cheaper generic Ozempic is here. Here’s what we’ve learned since these drugs exploded onto the scene

Opinion: Canada’s free ride on medicines is about to end
  • Jun 12, 2026

Opinion: Canada’s free ride on medicines is about to end

Medical delays 'not inevitable': Muscular Dystrophy Canada petitioning government to fast-track access to new treatments
  •  —
  • Jun 12, 2026

Medical delays 'not inevitable': Muscular Dystrophy Canada petitioning government to fast-track access to new treatments

Windsor pharmaceutical company expanding to make prescription drugs for cystic fibrosis patients
  • Jun 12, 2026

Windsor pharmaceutical company expanding to make prescription drugs for cystic fibrosis patients

Why Canada's Defence Strategy Needs Innovative Pharma
  • Jun 11, 2026

Why Canada's Defence Strategy Needs Innovative Pharma

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
  • Jun 11, 2026

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial

Get Canada’s essential briefing on health policy, science, and system change.  Get Briefing